Biometrik has Signed a Tender Contract for Candesartan Bioequivalence Study Facilitated by the Ministry of Health

Writer: Ega Astiana Nuzul Wahyuni; Editor: Oktaviani Utami Dewi

Depok, September 6th, 2023 - PT Biometrik Riset Indonesia has again won the tender held by the Ministry of Health of the Republic of Indonesia in order to provide Bioequivalence Study services to facilitate the pharmaceutical industries in changing the source of imported Candesartan raw materials to local raw materials.

More than 5 (five) Sentra Bioequivalence Study participated in this tender, but thanks to the hard work of all Biometrik employees, finally able to win the tender.

On September 5th, 2023, the contract between Biometrik with the Directorate General of Pharmaceutical and Medical Devices, Ministry of Health of the Republic of Indonesia was signed by Mr. Handoko Boedi Soetrisno President Director of PT Biometrik Riset Indonesia and Mr. Refiandes, S.Si., Apt., MPH Contract Signing Official of Directorate General of Pharmaceutical and Medical Devices, Ministry of Health of the Republic of Indonesia.

The six pharmaceutical industries participating in the facilitation of local change source raw materials of Candesartan from the Ministry of Health, i.e.:

1. PT Bernofarm
2. PT Hexpharm Jaya Laboratories
3. PT Interbat
4. PT Novell Pharmaceutical Laboratories
5. PT Pratapa Nirmala
6. PT Pyridam Farma Tbk.

Biometrik and the Ministry of Health hope the whole process will go smoothly and well with high quality. Biometrik also hopes that the change source of local raw materials pharmaceutical resilience in Indonesia will further increase.